These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9846274

  • 1. [Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum].
    Ishikane T.
    Hokkaido Igaku Zasshi; 1998 Sep; 73(5):441-9. PubMed ID: 9846274
    [Abstract] [Full Text] [Related]

  • 2. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
    Ishikane T, Kusumi I, Matsubara R, Matsubara S, Koyama T.
    Eur J Pharmacol; 1997 Feb 26; 321(2):163-9. PubMed ID: 9063684
    [Abstract] [Full Text] [Related]

  • 3. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
    Lucas G, De Deurwaerdère P, Caccia S, Umberto Spampinato.
    Neuropharmacology; 2000 Apr 03; 39(6):1053-63. PubMed ID: 10727716
    [Abstract] [Full Text] [Related]

  • 4. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.
    Szczepanik AM, Wilmot CA.
    Neurosci Lett; 1997 Aug 08; 231(2):91-4. PubMed ID: 9291148
    [Abstract] [Full Text] [Related]

  • 5. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J, Meltzer HY.
    Brain Res; 2000 Mar 10; 858(2):252-63. PubMed ID: 10708676
    [Abstract] [Full Text] [Related]

  • 6. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Apr 10; 273(1):101-12. PubMed ID: 7714755
    [Abstract] [Full Text] [Related]

  • 7. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049
    [Abstract] [Full Text] [Related]

  • 8. Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
    Dekeyne A, Rivet JM, Gobert A, Millan MJ.
    Neuropharmacology; 2001 Jun 27; 40(7):899-910. PubMed ID: 11378160
    [Abstract] [Full Text] [Related]

  • 9. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 10. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
    Sumiyoshi T, Ichikawa J, Meltzer HY.
    Neuropsychopharmacology; 1997 Mar 12; 16(3):183-90. PubMed ID: 9138434
    [Abstract] [Full Text] [Related]

  • 11. 5-HT(1A) and 5-HT(2A) receptors minimally contribute to clozapine-induced acetylcholine release in rat medial prefrontal cortex.
    Ichikawa J, Dai J, Meltzer HY.
    Brain Res; 2002 Jun 07; 939(1-2):34-42. PubMed ID: 12020849
    [Abstract] [Full Text] [Related]

  • 12. Serotonin 5-HT1A, 5-HT2A and dopamine D2 receptors strongly influence prefronto-hippocampal neural networks in alert mice: Contribution to the actions of risperidone.
    Gener T, Tauste Campo A, Alemany-González M, Nebot P, Delgado-Sallent C, Chanovas J, Puig MV.
    Neuropharmacology; 2019 Nov 01; 158():107743. PubMed ID: 31430459
    [Abstract] [Full Text] [Related]

  • 13. The receptor mechanisms underlying the disruptive effects of haloperidol and clozapine on rat maternal behavior: a double dissociation between dopamine D(2) and 5-HT(2A/2C) receptors.
    Zhao C, Li M.
    Pharmacol Biochem Behav; 2009 Oct 01; 93(4):433-42. PubMed ID: 19539643
    [Abstract] [Full Text] [Related]

  • 14. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS, Kulkarni SK.
    Eur J Pharmacol; 2001 Sep 28; 428(1):81-6. PubMed ID: 11779040
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of spinal 5-HT1A receptor activation and 5-HT2A/2C receptor desensitization by chronic haloperidol.
    Gajendiran M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1449-55. PubMed ID: 17688988
    [Abstract] [Full Text] [Related]

  • 16. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study).
    Sotnikova TD, Gainetdinov RR, Grekhova TV, Rayevsky KS.
    Pharmacol Res; 2001 Mar 01; 43(3):283-90. PubMed ID: 11401421
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain.
    Kusumi I, Takahashi Y, Suzuki K, Kameda K, Koyama T.
    J Neural Transm (Vienna); 2000 Mar 01; 107(3):295-302. PubMed ID: 10821438
    [Abstract] [Full Text] [Related]

  • 18. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J, Ishii H, Bonaccorso S, Fowler WL, O'Laughlin IA, Meltzer HY.
    J Neurochem; 2001 Mar 01; 76(5):1521-31. PubMed ID: 11238736
    [Abstract] [Full Text] [Related]

  • 19. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z, Ichikawa J, Huang M, Prus AJ, Dai J, Meltzer HY.
    Psychopharmacology (Berl); 2005 Dec 01; 183(2):144-53. PubMed ID: 16220333
    [Abstract] [Full Text] [Related]

  • 20. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U, Merico A, Ermani M, Ori C.
    Brain Res; 2010 Jun 04; 1335():24-34. PubMed ID: 20381465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.